Home › Funds › PRIMECAP MANAGEMENT CO/CA/ › BMY
PRIMECAP MANAGEMENT CO/CA/ position in BMY
BRISTOL-MYERS SQUIBB CO · Health Care
PRIMECAP MANAGEMENT CO/CA/ reported holding 25,199,726 shares of BMY (BRISTOL-MYERS SQUIBB CO) in its Q3 2026 13F filing — a position valued at US$1.57B, representing 0.98% of its reported portfolio and ranking #25 among its reported holdings. PRIMECAP MANAGEMENT CO/CA/ has disclosed BMY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How PRIMECAP MANAGEMENT CO/CA/'s BMY position evolved
PRIMECAP MANAGEMENT CO/CA/ first disclosed a stake in BMY in Q3 2023 at 20,536,150 shares (US$1.19B). The position peaked in Q3 2026 at 25,199,726 shares, worth US$1.57B. Across 13 filings, PRIMECAP MANAGEMENT CO/CA/ increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 25,199,726 shares valued at US$1.57B — an increase of 275,826 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 20.54M | $1.19B | New |
| Q4 2023 | 23.53M | $1.21B | Add |
| Q1 2024 | 23.27M | $1.26B | Reduce |
| Q2 2024 | 23.50M | $975.90M | Add |
| Q3 2024 | 23.37M | $1.21B | Reduce |
| Q4 2024 | 22.77M | $1.29B | Reduce |
| Q1 2025 | 22.97M | $1.40B | Add |
| Q2 2025 | 22.94M | $1.06B | Hold |
| Q3 2025 | 22.09M | $996.45M | Reduce |
| Q4 2025 | 24.88M | $1.34B | Add |
| Q1 2026 | 24.99M | $1.52B | Hold |
| Q2 2026 | 24.92M | $1.44B | Hold |
| Q3 2026 | 25.20M | $1.57B | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BMY and 13F data
BMY (BRISTOL-MYERS SQUIBB CO) is a Health Care company. 25 other funds we track also report a position in BMY — the largest reported positions include Charles Schwab Investment Management (US$3.89B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$3.89B), AQR Capital Management (US$1.58B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BMY
- Charles Schwab Investment Management 67.60M sh · $3.89B · Q2 2026
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 67.60M sh · $3.89B · Q2 2026
- AQR Capital Management 27.36M sh · $1.58B · Q2 2026
- AQR CAPITAL MANAGEMENT LLC 27.36M sh · $1.58B · Q2 2026
- Independent Franchise Partners LLP 21.54M sh · $1.34B · Q3 2026
- Pzena Investment Management 14.24M sh · $888.88M · Q3 2026
More on PRIMECAP MANAGEMENT CO/CA/
FAQ
How long has PRIMECAP MANAGEMENT CO/CA/ held BMY?
PRIMECAP MANAGEMENT CO/CA/ has disclosed BMY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is PRIMECAP MANAGEMENT CO/CA/'s current position in BMY?
As of Q3 2026, PRIMECAP MANAGEMENT CO/CA/ holds 25.20M shares of BMY (BRISTOL-MYERS SQUIBB CO), valued at $1.57B, representing 0.98% of its reported portfolio and ranking #25.
Has PRIMECAP MANAGEMENT CO/CA/ been buying or selling BMY?
In the latest 13F filing (Q3 2026), PRIMECAP MANAGEMENT CO/CA/ increased its position in BMY. The position peaked in Q3 2026 at 25.20M shares.
Which other funds hold BMY?
Other major institutional holders of BMY include Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, AQR Capital Management, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.